GO:0016598 protein arginylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016598 (protein arginylation) is the conjugation of arginine to the N-terminal aspartate or glutamate of a protein, a modification required for degradation of the protein via the ubiquitin pathway.
• Protein arginylation is a post-translational modification that was discovered over 50 years ago and is now recognized as a global biological regulator.
• The process targets cytoskeletal proteins such as actin and is particularly important in muscle and the nervous system.
• Arginylation regulates G-protein signaling in the retina, linking the modification to sensory physiology.
• Protein arginylation is dynamically regulated during SARS-CoV-2 infection, indicating a role in host-pathogen interactions.
• Dysregulation of arginylation is implicated in neurodegeneration and other disease states, making it a research target for CRISPR-based models.
Description
Protein arginylation (GO:0016598) is a post-translational modification in which the amino acid arginine is covalently attached to the N-terminal aspartate or glutamate residue of a target protein. This conjugation reaction is required for the degradation of the modified protein through the ubiquitin pathway, thereby controlling protein stability and turnover. Since its discovery more than five decades ago, arginylation has emerged as a global biological regulator that influences diverse cellular processes, including cytoskeletal dynamics, muscle function, and neuronal development. The modification is conserved and essential in higher eukaryotes, and its study has revealed fundamental principles of N-terminal protein processing and degradation. Researchers study protein arginylation to understand how cells regulate protein lifetimes, how cytoskeletal networks are remodeled, and how defects in this pathway contribute to human disease. The process is also emerging as a factor in host responses to infection, as shown by its regulation during SARS-CoV-2 infection. Because arginylation can alter protein function and stability, it represents a promising area for therapeutic intervention and for the development of CRISPR-based disease models.
protein arginylation At A Glance
| GO ID | GO:0016598 |
|---|---|
| GO term | protein arginylation |
| Ontology | biological_process |
| Synonym | protein amino acid arginylation |
| Definition | The conjugation of arginine to the N-terminal aspartate or glutamate of a protein; required for the degradation of the protein via the ubiquitin pathway. |
| Major function | Targets proteins for ubiquitin-mediated degradation and regulates cytoskeletal and signaling proteins. |
| Key enzyme | Arginyl-tRNA-protein transferase (ATE1). |
| Subcellular context | Cytoplasm and cytoskeleton-associated compartments. |
| Physiological relevance | Muscle function, nervous system development, retinal signaling, and infection responses. |
What Is GO:0016598?
Protein arginylation is the enzymatic conjugation of an arginine residue to the N-terminal aspartate or glutamate of a protein. This post-translational modification serves as a signal for the ubiquitin-mediated degradation of the modified protein. The reaction is catalyzed by arginyl-tRNA-protein transferase (ATE1) and uses arginyl-tRNA as the arginine donor. The modification is distinct from other N-terminal modifications because it specifically targets acidic N-terminal residues and creates a degradation signal.
Why Is protein arginylation Important in Cell Biology?
Protein arginylation is important because it provides a fundamental mechanism for controlling protein stability through the ubiquitin pathway, thereby influencing a wide range of cellular processes. It is a global regulator that targets cytoskeletal proteins such as actin, affecting cell shape, motility, and muscle contraction. In the nervous system, arginylation is essential for normal development and function, and its dysregulation has been linked to neurodegeneration. The modification also plays a role in G-protein signaling in the retina, highlighting its importance in sensory physiology. Furthermore, the dynamic regulation of arginylation during SARS-CoV-2 infection suggests that it participates in host-pathogen interactions and may influence viral pathogenesis. Understanding protein arginylation therefore has broad implications for cell biology, physiology, and disease research.
• Controls protein degradation via the ubiquitin pathway, affecting protein turnover.
• Regulates actin cytoskeleton dynamics and muscle function.
• Essential for normal nervous system development and function.
• Modulates G-protein signaling in the retina.
• Is dynamically regulated during SARS-CoV-2 infection.
• Represents a conserved post-translational modification with over 50 years of research history.
• Implicated in neurodegeneration and other disease states.
• Provides a potential target for therapeutic intervention.
• Serves as a model for studying N-terminal protein processing.
• Can be studied using CRISPR-based knockout and knock-in models.
What Happens During protein arginylation?
Recognition of N-terminal acidic residues
In simple terms: The process starts when a protein exposes an aspartate or glutamate at its N-terminus.
Protein arginylation begins with the recognition of a target protein that has an N-terminal aspartate or glutamate residue. These acidic residues are generated either during translation or after proteolytic cleavage of a larger precursor. The N-terminal region must be accessible to the arginyl-tRNA-protein transferase (ATE1) enzyme for the modification to occur.
Transfer of arginine from arginyl-tRNA
In simple terms: An enzyme attaches an arginine building block to the protein's front end.
The enzyme ATE1 catalyzes the transfer of arginine from arginyl-tRNA to the N-terminal aspartate or glutamate of the target protein. This reaction forms a peptide bond between the arginine and the acidic residue, creating a new N-terminus. The use of arginyl-tRNA as a donor links arginylation to the translational machinery and amino acid availability.
Formation of a degradation signal
In simple terms: The added arginine acts like a tag that marks the protein for destruction.
The addition of arginine creates a degradation signal that is recognized by the ubiquitin-proteasome system. This signal is required for the ubiquitination of the modified protein, which then leads to its degradation. The arginylation-dependent degradation pathway is a key mechanism for eliminating specific proteins.
Ubiquitin-mediated degradation
In simple terms: The tagged protein is broken down by the cell's recycling machinery.
Following arginylation, the target protein is conjugated with ubiquitin and subsequently degraded by the proteasome. This process is essential for maintaining protein homeostasis and for regulating the levels of short-lived or damaged proteins. The degradation of arginylated proteins influences diverse cellular functions, including cytoskeletal remodeling and signal transduction.
Physiological roles in muscle and neurons
In simple terms: Arginylation helps muscles work and nerves develop properly.
In muscle, arginylation of cytoskeletal proteins modifies their function and contributes to contractile activity. In the nervous system, arginylation is required for normal development and function, and its disruption leads to neurodegeneration. The modification also regulates G-protein signaling in the retina, affecting visual responses.
Key Genes Involved in GO:0016598 protein arginylation
The following genes and proteins are central to protein arginylation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATE1 | Catalyzes the transfer of arginine to N-terminal aspartate or glutamate | Core enzyme for studying arginylation; knockout models reveal its essential functions |
| ACTB | Actin, a major target of arginylation in the cytoskeleton | Arginylation regulates actin dynamics and muscle function |
| ACTG1 | Gamma-actin, another cytoskeletal target | Implicated in cytoskeletal regulation and muscle physiology |
| TUBB | Tubulin, a target of arginylation in neurons | Arginylation affects microtubule stability and neuronal development |
| GNAI1 | G-protein subunit regulated by arginylation in the retina | Links arginylation to G-protein signaling and vision |
| GNAO1 | G-protein subunit potentially regulated by arginylation | Relevant to retinal signaling and neuronal function |
| MYH9 | Myosin heavy chain, a cytoskeletal protein affected by arginylation | Arginylation influences muscle contraction and cytoskeletal organization |
| TPM1 | Tropomyosin, a cytoskeletal target | Arginylation modulates actin-myosin interactions in muscle |
| VCL | Vinculin, a focal adhesion protein | Arginylation may affect cell adhesion and cytoskeletal linkage |
| FLNA | Filamin A, an actin-crosslinking protein | Arginylation contributes to cytoskeletal network regulation |
| PFN1 | Profilin 1, an actin-binding protein | Arginylation impacts actin polymerization dynamics |
| CFL1 | Cofilin 1, an actin-depolymerizing factor | Arginylation may regulate actin turnover |
| SARS-CoV-2 proteins | Viral proteins that interact with the arginylation machinery | Arginylation is regulated during infection, suggesting host-pathogen interplay |
| RPLP0 | Ribosomal protein, potential target of arginylation | Links arginylation to translation and ribosome function |
| HSPA1A | Heat shock protein, may be affected by arginylation | Arginylation could influence protein quality control |
| UBB | Ubiquitin, involved in degradation of arginylated proteins | Central to the ubiquitin-proteasome pathway |
| PSMD1 | Proteasome subunit, mediates degradation of arginylated proteins | Key component of the degradation machinery |
How Is protein arginylation Regulated?
Protein arginylation is regulated at multiple levels. The expression and activity of ATE1, the enzyme responsible for arginylation, can be modulated by cellular conditions. The availability of arginyl-tRNA, which depends on amino acid supply and tRNA charging, influences the rate of arginylation. Additionally, the accessibility of N-terminal acidic residues on target proteins, which can be generated by proteolytic cleavage or alternative translation initiation, determines substrate specificity. During SARS-CoV-2 infection, arginylation is dynamically regulated, suggesting that viral factors or host immune responses can alter the pathway. In the nervous system, arginylation is developmentally regulated and responds to neuronal activity. These regulatory mechanisms ensure that arginylation is properly timed and targeted to specific proteins.
protein arginylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATE1 | Neurodegeneration, muscle dysfunction | Ate1 knockout mouse or CRISPR knockout cell lines |
| ACTB | Muscle weakness, cytoskeletal disorders | Actb point mutation or knockout in muscle cells |
| TUBB | Neurodegeneration, neuronal development defects | Tubb knockout or knock-in in neurons |
| GNAI1 | Retinal signaling defects | Gnai1 knockout in retinal cells |
| SARS-CoV-2 proteins | COVID-19 pathogenesis | Infection models with arginylation pathway knockouts |
Protein arginylation in neurodegeneration
Dysregulation of protein arginylation has been implicated in neurodegenerative processes. In the nervous system, arginylation is essential for normal development and function, and its disruption leads to neuronal defects. Studies suggest that impaired arginylation may contribute to the accumulation of damaged proteins and neurodegeneration. The modification of cytoskeletal proteins such as tubulin by arginylation affects neuronal morphology and transport, and its failure may underlie certain neurodegenerative conditions.
Protein arginylation in muscle function and disease
Arginylation of cytoskeletal proteins in muscle modifies their function and is required for normal muscle physiology. Defects in arginylation can lead to muscle weakness and structural abnormalities. The modification targets actin and other contractile proteins, influencing muscle contraction and maintenance. Research into muscle arginylation may provide insights into myopathies and muscle wasting conditions.
Protein arginylation in retinal signaling and vision
Arginylation regulates G-protein signaling in the retina, and its disruption can affect visual responses. The modification of G-protein subunits by arginylation modulates signal transduction in photoreceptors. This link suggests that arginylation defects may contribute to retinal degenerative diseases.
Protein arginylation in infectious disease
Protein arginylation is regulated during SARS-CoV-2 infection, indicating a role in host-pathogen interactions. The modification may affect viral replication or the host immune response. Understanding how arginylation is altered during infection could reveal new therapeutic targets.
From protein arginylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of ATE1 in protein arginylation? | ATE1 knockout cell line or mouse |
| How does arginylation affect actin dynamics? | ACTB point mutation or tagged knock-in |
| Does arginylation regulate G-protein signaling in the retina? | GNAI1 knockout in retinal cells |
| What proteins are targeted by arginylation during infection? | Overexpression of viral proteins in arginylation-competent cells |
| How does arginylation influence neuronal development? | TUBB knockout or knock-in in neuronal cultures |
| Can arginylation be used to study protein degradation? | Tagged knock-in of target proteins with degradation reporters |
How to Study the protein arginylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Identification of arginylated peptides | Global profiling of arginylation substrates |
| In vitro arginylation assay | Enzyme activity and substrate specificity | Characterizing ATE1 function |
| Immunofluorescence | Localization of arginylated proteins | Visualizing cytoskeletal modifications |
| Live-cell imaging | Dynamics of arginylated proteins | Studying actin and tubulin behavior |
| CRISPR knockout | Loss-of-function effects | Determining the role of ATE1 or targets |
| CRISPR point mutation | Site-specific disruption of arginylation | Mapping functional arginylation sites |
| CRISPR knock-in | Tagged protein tracking | Monitoring degradation of arginylated proteins |
| RNA-seq | Transcriptional changes upon arginylation loss | Identifying downstream pathways |
Proteomic identification of arginylated proteins
Mass spectrometry-based proteomics can identify proteins bearing N-terminal arginine modifications. Enrichment of arginylated peptides followed by tandem mass spectrometry allows global profiling of substrates. This approach has revealed that arginylation targets a wide range of cytoskeletal and metabolic proteins.
Biochemical assays for arginylation activity
In vitro arginylation assays using purified ATE1 and arginyl-tRNA can measure the transfer of arginine to substrate proteins. These assays are useful for determining substrate specificity and enzyme kinetics. They can also be adapted to screen for inhibitors or activators of arginylation.
Imaging of arginylated proteins in cells
Fluorescent tagging or immunofluorescence with antibodies specific for arginylated proteins can visualize their localization. Live-cell imaging of tagged actin or tubulin can reveal how arginylation affects cytoskeletal dynamics. Imaging in retinal or neuronal cells can show the impact of arginylation on signaling and development.
Genetic manipulation using CRISPR
CRISPR-Cas9 knockout of ATE1 or target genes allows functional studies of arginylation. Point mutations can be introduced to disrupt specific arginylation sites. Knock-in of tagged versions of target proteins enables tracking of their fate after arginylation.
How CRISPR Can Be Used to Study GO:0016598 protein arginylation
Knockout
CRISPR knockout of ATE1 or specific target genes is used to study the loss of protein arginylation. Knockout cell lines and animal models reveal the physiological consequences of arginylation deficiency, such as cytoskeletal defects and neurodegeneration. These models are essential for understanding the essential functions of arginylation in development and disease.
Point Mutation
Point mutations can be introduced into the N-terminal region of target proteins to prevent arginylation. Such mutations allow researchers to distinguish the effects of arginylation from other modifications. For example, mutating the N-terminal aspartate or glutamate of actin can block its arginylation and reveal its role in cytoskeletal dynamics.
Knock-in
Knock-in of tagged versions of target proteins, such as GFP-actin, enables real-time tracking of arginylation and degradation. Tagged knock-in models can also be used to study the localization and turnover of arginylated proteins in vivo. These models are valuable for understanding how arginylation affects protein fate.
Overexpression
Overexpression of ATE1 or target proteins can enhance arginylation and reveal its effects on cellular processes. Overexpression models are useful for studying gain-of-function phenotypes and for identifying downstream targets. They can also be used to investigate the role of arginylation in viral infection by overexpressing viral proteins.
How EDITGENE Supports protein arginylation Research
Researchers studying protein arginylation-related genes often need to determine whether a candidate gene is causally involved in the pathway or in disease. EDITGENE provides comprehensive CRISPR-based services to create knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support. These tools enable precise functional interrogation of arginylation components and their targets.
Contact EDITGENE today to design your custom CRISPR model for protein arginylation research.
Frequently Asked Questions About protein arginylation
What is protein arginylation?
Protein arginylation is the conjugation of arginine to the N-terminal aspartate or glutamate of a protein, which targets the protein for degradation via the ubiquitin pathway.
What genes are involved in protein arginylation?
The key gene is ATE1, which encodes the enzyme that catalyzes arginylation; target genes include ACTB, TUBB, and GNAI1.
What is the GO ID for protein arginylation?
The GO ID is GO:0016598.
How does protein arginylation regulate protein degradation?
Arginylation creates a degradation signal that is recognized by the ubiquitin-proteasome system, leading to protein breakdown.
What is the role of ATE1 in arginylation?
ATE1 is the enzyme that transfers arginine from arginyl-tRNA to target proteins, initiating their degradation.
Is protein arginylation involved in disease?
Yes, it is implicated in neurodegeneration, muscle dysfunction, retinal signaling defects, and SARS-CoV-2 infection.
How can I study protein arginylation using CRISPR?
CRISPR knockout of ATE1 or target genes, point mutations to block arginylation sites, and knock-in of tagged proteins are common approaches.
What methods are used to detect protein arginylation?
Mass spectrometry, in vitro assays, immunofluorescence, and live-cell imaging are used to detect and study arginylation.
What is the role of arginylation in the nervous system?
Arginylation is essential for neuronal development and function, and its disruption leads to neurodegeneration.
How does arginylation affect muscle function?
Arginylation modifies cytoskeletal proteins in muscle, influencing contraction and structural integrity.
Conclusion
Protein arginylation (GO:0016598) is a fundamental post-translational modification that controls protein degradation and regulates diverse physiological processes, from cytoskeletal dynamics to neuronal function and infection responses. Its study has provided key insights into N-terminal protein processing and the ubiquitin pathway. Dysregulation of arginylation is linked to neurodegeneration, muscle disorders, and retinal defects, making it a compelling target for further research. Advances in CRISPR-based models and proteomic methods will continue to unravel the mechanisms and therapeutic potential of this modification.
References
- 1. Rassier DE et al.. 2019. Protein arginylation of cytoskeletal proteins in the muscle: modifications modifying function.. Am J Physiol Cell Physiol 316(5):C668-C677 PMID: 30789755
- 2. Macedo-da-Silva J et al.. 2023. Protein Arginylation Is Regulated during SARS-CoV-2 Infection.. Viruses 15(2) PMID: 36851505
- 3. Kashina AS. 2015. Protein Arginylation: Over 50 Years of Discovery.. Methods Mol Biol 1337:1-11 PMID: 26285874
- 4. Kashina AS. 2023. Protein Arginylation: Milestones of Discovery.. Methods Mol Biol 2620:1-13 PMID: 37010742
- 5. Fina ME et al.. 2021. Arginylation Regulates G-protein Signaling in the Retina.. Front Cell Dev Biol 9:807345 PMID: 35127722
- 6. Eldeeb MA et al.. 2018. Post-translational N-terminal Arginylation of Protein Fragments: A Pivotal Portal to Proteolysis.. Curr Protein Pept Sci 19(12):1214-1223 PMID: 30091410
- 7. Kashina A. 2014. Protein arginylation, a global biological regulator that targets actin cytoskeleton and the muscle.. Anat Rec (Hoboken) 297(9):1630-6 PMID: 25125176
- 8. Galiano MR et al.. 2016. Post-translational protein arginylation in the normal nervous system and in neurodegeneration.. J Neurochem 138(4):506-17 PMID: 27318192
